What Your Prescriptions Cost
How much does Entresto cost with Medicare in 2026?
Last reviewed: · Big Sioux Benefits Data Desk
Entresto has a Medicare-negotiated price of $295 for a 30-day supply as of January 1, 2026, down from a list price of $628, a 53% reduction (CMS, Negotiated Prices for Initial Price Applicability Year 2026). About 664,000 Medicare beneficiaries used it in 2023, accounting for $3.4 billion in Part D gross covered drug costs.
The qualifier: Entresto is a heart failure drug, and heart failure is rarely treated with one medication. Patients commonly take it alongside a beta blocker, a diuretic, and increasingly an SGLT2 inhibitor such as Jardiance or Farxiga. That stacking is why heart failure patients are among the most likely to reach the annual out-of-pocket cap, and why looking at Entresto's price in isolation understates the year.
What a year on Entresto looks like
| Step | Illustration under the standard 2026 benefit |
|---|---|
| Drug cost for the year at the negotiated price | About $3,540 |
| You pay during the deductible | Up to $615 |
| You pay after the deductible | 25% of the remaining cost, about $731 |
| Approximate out-of-pocket for the year | About $1,346, under the $2,100 cap on this drug alone |
How this illustration is built: the 2026 standard Part D benefit, meaning a full $615 deductible, then 25% coinsurance, then $0 once your out-of-pocket total reaches $2,100. Your plan may use copays instead of coinsurance, may charge a smaller deductible or none, and may place the drug on a different tier, so treat this as the shape of the year rather than a quote. We are not showing plan-specific copays because we will not publish a number we cannot source.
Read that last line carefully: about $1,346 on this drug alone. Add a negotiated SGLT2 inhibitor at roughly $1,000 a year in cost sharing and you are at the $2,100 cap before the year is out, at which point everything else is free. For anyone on a multi-drug heart failure regimen, the cap is not a theoretical ceiling, it is the number to plan around, and the Medicare Prescription Payment Plan is the tool for spreading it.
Sources
- CMS — Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 — prices effective January 1, 2026; accessed 2026-08-21
- CMS — Medicare Part D Spending by Drug — CY2025 full year and CY2026 Q1 files; accessed 2026-08-21
- CMS — Announcement of Calendar Year 2026 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies (Part D benefit parameters) — CY2026 parameters; accessed 2026-08-21
Related questions
Is there a generic for Entresto?
Entresto was selected for negotiation under a statutory requirement that the drug have no generic or biosimilar competition at the time of selection. Generic entry has been the subject of ongoing litigation. Ask your pharmacist what is actually available to fill, since approval and availability are not the same thing.
I take Entresto and Jardiance. Will I hit the $2,100 cap?
On the illustration figures, quite likely. Entresto alone runs roughly $1,346 in out-of-pocket cost across a year under the standard benefit, and Jardiance roughly $1,052. Together that exceeds $2,100, meaning you would reach the cap partway through the year and pay nothing for covered drugs after that.
Drug costs turn on your specific prescriptions, so the arithmetic is worth doing once, properly: book a free, no-pressure conversation, see your county's South Dakota plan lineup, or browse all answers. SHIINE, the state's free counseling program, is at 1-800-536-8197 and sells nothing.
Big Sioux Benefits is a licensed insurance agency, not affiliated with or endorsed by the U.S. government or the federal Medicare program. We do not offer every plan available in your area. Contact Medicare.gov, 1-800-MEDICARE, or SHIINE (South Dakota's SHIP) for all of your options.